Observational studyEuropean heart journal. Cardiovascular pharmacotherapy2020

Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study.

Ole-Christian W Rutherford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.